Exact Mass: 626.4394

Peltatol C

C42H58O4 (626.4335)

Peltatol C is found in herbs and spices. Peltatol C is a constituent of Pothomorphe peltata (Piperaceae). Constituent of Pothomorphe peltata (Piperaceae). Peltatol C is found in herbs and spices.

Peltatol B

C42H58O4 (626.4335)

Peltatol B is found in herbs and spices. Peltatol B is a constituent of Pothomorphe peltata. Constituent of Pothomorphe peltata. Peltatol B is found in herbs and spices.

Peltatol A

C42H58O4 (626.4335)

Peltatol A is found in herbs and spices. Peltatol A is a constituent of Pothomorphe peltata. Constituent of Pothomorphe peltata. Peltatol A is found in herbs and spices.

Pregna-1,9(11)-diene-3,20-dione, 21-(4-(2,6-di-1-pyrrolidinyl-4-pyrimidinyl)-1-piperazinyl)-16-methyl-, (5beta,16alpha)-

C38H54N6O2 (626.4308)

DG(12:0/6 keto-PGF1alpha/0:0)

C35H62O9 (626.4394)

DG(12:0/6 keto-PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/6 keto-PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(6 keto-PGF1alpha/12:0/0:0)

C35H62O9 (626.4394)

DG(6 keto-PGF1alpha/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(6 keto-PGF1alpha/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/6 keto-PGF1alpha)

C35H62O9 (626.4394)

DG(12:0/0:0/6 keto-PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(6 keto-PGF1alpha/0:0/12:0)

C35H62O9 (626.4394)

DG(6 keto-PGF1alpha/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(12:0/TXB2/0:0)

C35H62O9 (626.4394)

DG(12:0/TXB2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(12:0/TXB2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(TXB2/12:0/0:0)

C35H62O9 (626.4394)

DG(TXB2/12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(TXB2/12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(12:0/0:0/TXB2)

C35H62O9 (626.4394)

DG(12:0/0:0/TXB2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(TXB2/0:0/12:0)

C35H62O9 (626.4394)

DG(TXB2/0:0/12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(13:0/PGF1alpha/0:0)

C36H66O8 (626.4757)

DG(13:0/PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGF1alpha/13:0/0:0)

C36H66O8 (626.4757)

DG(PGF1alpha/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGF1alpha/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(13:0/0:0/PGF1alpha)

C36H66O8 (626.4757)

DG(13:0/0:0/PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGF1alpha/0:0/13:0)

C36H66O8 (626.4757)

DG(PGF1alpha/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/PGF1alpha/0:0)

C36H66O8 (626.4757)

DG(a-13:0/PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGF1alpha/a-13:0/0:0)

C36H66O8 (626.4757)

DG(PGF1alpha/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGF1alpha/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(a-13:0/0:0/PGF1alpha)

C36H66O8 (626.4757)

DG(a-13:0/0:0/PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGF1alpha/0:0/a-13:0)

C36H66O8 (626.4757)

DG(PGF1alpha/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/6 keto-PGF1alpha/0:0)

C35H62O9 (626.4394)

DG(i-12:0/6 keto-PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/6 keto-PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(6 keto-PGF1alpha/i-12:0/0:0)

C35H62O9 (626.4394)

DG(6 keto-PGF1alpha/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(6 keto-PGF1alpha/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/6 keto-PGF1alpha)

C35H62O9 (626.4394)

DG(i-12:0/0:0/6 keto-PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(6 keto-PGF1alpha/0:0/i-12:0)

C35H62O9 (626.4394)

DG(6 keto-PGF1alpha/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/TXB2/0:0)

C35H62O9 (626.4394)

DG(i-12:0/TXB2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-12:0/TXB2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(TXB2/i-12:0/0:0)

C35H62O9 (626.4394)

DG(TXB2/i-12:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(TXB2/i-12:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-12:0/0:0/TXB2)

C35H62O9 (626.4394)

DG(i-12:0/0:0/TXB2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(TXB2/0:0/i-12:0)

C35H62O9 (626.4394)

DG(TXB2/0:0/i-12:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/PGF1alpha/0:0)

C36H66O8 (626.4757)

DG(i-13:0/PGF1alpha/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/PGF1alpha/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(PGF1alpha/i-13:0/0:0)

C36H66O8 (626.4757)

DG(PGF1alpha/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGF1alpha/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(i-13:0/0:0/PGF1alpha)

C36H66O8 (626.4757)

DG(i-13:0/0:0/PGF1alpha) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(PGF1alpha/0:0/i-13:0)

C36H66O8 (626.4757)

DG(PGF1alpha/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Buxmicrophylline E

C40H54N2O4 (626.4083)

C39H62O6

C39H62O6 (626.4546)

77573-06-9

C39H62O6 (626.4546)

(+)-lariciresinol 9-stearate|octadecanoic acid {(2S,3R,4R)-tetrahydro-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]furan-3-yl}methyl ester

C38H58O7 (626.4182)

Peltatol C

C42H58O4 (626.4335)

laeviuscoloside H

C34H58O10 (626.403)

(5beta,4beta,5beta,7alpha,24?)6-Chloro-4,5-epoxystigmastan-3-ol

C35H59ClO7 (626.3949)

C34H58O10

C34H58O10 (626.403)

3beta,14alpha,15alpha,21alpha-tetrahydroxyserrat-14-en-3-(3-methoxyl-4-hydroxybenzoate)

C38H58O7 (626.4182)

6-aureoxyaureol

C42H58O4 (626.4335)

(25R)-22-O-methyl-5alpha-furostane-2alpha,3beta,22xi,26-tetrol 26-O-beta-D-glucopyranoside

C34H58O10 (626.403)

C42H58O4

C42H58O4 (626.4335)

cylindrocyclophane B

C38H58O7 (626.4182)

CHEMBL447721

C38H58O7 (626.4182)

(34RS)-montanacin H

C35H62O9 (626.4394)

(24R)-242-O-beta-(4-O-methyl-D-xylopyranosyl)-24-ethyl-5alpha-cholestane-3beta,6alpha,15beta,16beta,242-pentol|certonardoside O1

C35H62O9 (626.4394)

Leu Arg Pro Thr Leu

C29H54N8O7 (626.4115)

castasterone-23-O-glucoside

C34H58O10 (626.403)

8-(3,4-dihydroxy-5-alkenyl)phenyl-3-[9E,11E,13Z-pentadecatrienyl]catechol

C42H58O4 (626.4335)

Somocystinamide A byproduct

C32H58N4O4S2 (626.3899)

PA(13:0/18:4(6Z,9Z,12Z,15Z))

C34H59O8P (626.3947)

PA(18:4(6Z,9Z,12Z,15Z)/13:0)

C34H59O8P (626.3947)

Peltatol B

C42H58O4 (626.4335)

Peltatol A

C42H58O4 (626.4335)

PA 31:4

C34H59O8P (626.3947)

2-Hydroxyflexixanthin dimethyl ether

C42H58O4 (626.4335)

Deepoxydinoxanthin

C42H58O4 (626.4335)

tris[2-[2-(2-Butoxyethoxy)ethoxy]ethyl]orthoborate

C30H63BO12 (626.4412)

zinc dioleate

C36H66O4Zn (626.4252)

Anapoe-C12E10

C32H66O11 (626.4605)

Tocofibrate

C39H59ClO4 (626.4102)

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

5beta,20-O,O-Isopropylidineingenol, 3beta-palmitate

C39H62O6 (626.4546)

6-O-(Glcb)-(25R)-5alpha-spirostan-3beta,6alpha,23S-triol

C34H58O10 (626.403)

2-Hydroxy-2-oxospirilloxanthin

C42H58O4 (626.4335)

Urushiol dimer

C42H58O4 (626.4335)

Dimeric urushiol

C42H58O4 (626.4335)

DG(13:0/PGF1alpha/0:0)

C36H66O8 (626.4757)

DG(PGF1alpha/13:0/0:0)

C36H66O8 (626.4757)

DG(13:0/0:0/PGF1alpha)

C36H66O8 (626.4757)

DG(PGF1alpha/0:0/13:0)

C36H66O8 (626.4757)

DG(a-13:0/PGF1alpha/0:0)

C36H66O8 (626.4757)

DG(PGF1alpha/a-13:0/0:0)

C36H66O8 (626.4757)

DG(a-13:0/0:0/PGF1alpha)

C36H66O8 (626.4757)

DG(PGF1alpha/0:0/a-13:0)

C36H66O8 (626.4757)

DG(i-13:0/PGF1alpha/0:0)

C36H66O8 (626.4757)

DG(PGF1alpha/i-13:0/0:0)

C36H66O8 (626.4757)

DG(i-13:0/0:0/PGF1alpha)

C36H66O8 (626.4757)

DG(PGF1alpha/0:0/i-13:0)

C36H66O8 (626.4757)

DG(12:0/6 keto-PGF1alpha/0:0)

C35H62O9 (626.4394)

DG(6 keto-PGF1alpha/12:0/0:0)

C35H62O9 (626.4394)

DG(12:0/0:0/6 keto-PGF1alpha)

C35H62O9 (626.4394)

DG(6 keto-PGF1alpha/0:0/12:0)

C35H62O9 (626.4394)

DG(12:0/TXB2/0:0)

C35H62O9 (626.4394)

DG(TXB2/12:0/0:0)

C35H62O9 (626.4394)

DG(12:0/0:0/TXB2)

C35H62O9 (626.4394)

DG(TXB2/0:0/12:0)

C35H62O9 (626.4394)

DG(i-12:0/TXB2/0:0)

C35H62O9 (626.4394)

DG(TXB2/i-12:0/0:0)

C35H62O9 (626.4394)

DG(i-12:0/0:0/TXB2)

C35H62O9 (626.4394)

DG(TXB2/0:0/i-12:0)

C35H62O9 (626.4394)

DG(i-12:0/6 keto-PGF1alpha/0:0)

C35H62O9 (626.4394)

DG(6 keto-PGF1alpha/i-12:0/0:0)

C35H62O9 (626.4394)

DG(i-12:0/0:0/6 keto-PGF1alpha)

C35H62O9 (626.4394)

DG(6 keto-PGF1alpha/0:0/i-12:0)

C35H62O9 (626.4394)

NAGlySer 11:0/19:0

C35H66N2O7 (626.487)

NAGlySer 15:0/15:0

C35H66N2O7 (626.487)

NAGlySer 19:0/11:0

C35H66N2O7 (626.487)

NAGlySer 10:0/20:0

C35H66N2O7 (626.487)

NAGlySer 16:0/14:0

C35H66N2O7 (626.487)

NAGlySer 13:0/17:0

C35H66N2O7 (626.487)

NAGlySer 20:0/10:0

C35H66N2O7 (626.487)

NAGlySer 12:0/18:0

C35H66N2O7 (626.487)

NAGlySer 17:0/13:0

C35H66N2O7 (626.487)

NAGlySer 14:0/16:0

C35H66N2O7 (626.487)

NAGlySer 18:0/12:0

C35H66N2O7 (626.487)

NAOrn 16:4/17:2

C38H62N2O5 (626.4658)

NAOrn 22:6/11:0

C38H62N2O5 (626.4658)

NAOrn 18:5/15:1

C38H62N2O5 (626.4658)

NAOrn 20:5/13:1

C38H62N2O5 (626.4658)

Mgdg O-20:3_6:0

C35H62O9 (626.4394)

Mgdg O-18:3_8:0

C35H62O9 (626.4394)

Mgdg O-8:0_18:3

C35H62O9 (626.4394)

Mgdg O-24:3_2:0

C35H62O9 (626.4394)

Mgdg O-22:3_4:0

C35H62O9 (626.4394)

Mgdg O-10:0_16:3

C35H62O9 (626.4394)

Mgdg O-16:3_10:0

C35H62O9 (626.4394)

PE-Cer 16:3;2O/16:1

C34H63N2O6P (626.4424)

PE-Cer 12:0;2O/20:4

C34H63N2O6P (626.4424)

PE-Cer 18:3;2O/14:1

C34H63N2O6P (626.4424)

PE-Cer 12:2;2O/20:2

C34H63N2O6P (626.4424)

PE-Cer 14:3;2O/18:1

C34H63N2O6P (626.4424)

PE-Cer 14:0;2O/18:4

C34H63N2O6P (626.4424)

PE-Cer 14:1;2O/18:3

C34H63N2O6P (626.4424)

PE-Cer 16:1;2O/16:3

C34H63N2O6P (626.4424)

PE-Cer 15:3;2O/17:1

C34H63N2O6P (626.4424)

PE-Cer 14:2;2O/18:2

C34H63N2O6P (626.4424)

PE-Cer 12:1;2O/20:3

C34H63N2O6P (626.4424)

PE-Cer 15:2;2O/17:2

C34H63N2O6P (626.4424)

PE-Cer 13:2;2O/19:2

C34H63N2O6P (626.4424)

PE-Cer 19:3;2O/13:1

C34H63N2O6P (626.4424)

PE-Cer 17:3;2O/15:1

C34H63N2O6P (626.4424)

PE-Cer 16:2;2O/16:2

C34H63N2O6P (626.4424)

PE-Cer 16:0;2O/16:4

C34H63N2O6P (626.4424)

PE-Cer 15:3;2O/16:2;O

C33H59N2O7P (626.406)

[(E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]non-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[(E)-3-hydroxy-2-[[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyl]amino]undec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[2-[[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]amino]-3-hydroxytridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]hexadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[(4E,8E)-2-[[(9Z,12Z)-heptadeca-9,12-dienoyl]amino]-3-hydroxydodeca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[(4E,8E)-2-[[(9Z,12Z)-hexadeca-9,12-dienoyl]amino]-3-hydroxytrideca-4,8-dienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[(E)-2-[[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoyl]amino]-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[3-hydroxy-2-[[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]amino]undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

PEtOH 13:0_16:4

C34H59O8P (626.3947)

PEtOH 13:1_16:3

C34H59O8P (626.3947)

PMeOH 14:0_16:4

C34H59O8P (626.3947)

PMeOH 14:1_16:3

C34H59O8P (626.3947)

PMeOH 12:0_18:4

C34H59O8P (626.3947)

[1-pentanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate

C34H58O10 (626.403)

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C34H58O10 (626.403)

[1-nonanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C34H58O10 (626.403)

[1-heptanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C34H58O10 (626.403)

[3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]nonyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]pentadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[(4E,8E,12E)-3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]tetradeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

(1-nonanoyloxy-3-phosphonooxypropan-2-yl) (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C34H59O8P (626.3947)

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

C34H59O8P (626.3947)

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate

C34H59O8P (626.3947)

[1-phosphonooxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C34H59O8P (626.3947)

(1-phosphonooxy-3-tridecanoyloxypropan-2-yl) (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C34H59O8P (626.3947)

(1-phosphonooxy-3-undecanoyloxypropan-2-yl) (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C34H59O8P (626.3947)

(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C34H59O8P (626.3947)

[1-[(Z)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C34H59O8P (626.3947)

[(4E,8E,12E)-3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]hexadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[2-[(6Z,9Z)-dodeca-6,9-dienoyl]oxy-3-[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxypropyl] (Z)-dodec-5-enoate

C39H62O6 (626.4546)

2,3-bis[[(6Z,9Z)-dodeca-6,9-dienoyl]oxy]propyl (6Z,9Z)-dodeca-6,9-dienoate

C39H62O6 (626.4546)

2,3-bis[[(3Z,6Z,9Z)-dodeca-3,6,9-trienoyl]oxy]propyl dodecanoate

C39H62O6 (626.4546)

[(4E,8E,12E)-2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxyheptadeca-4,8,12-trienyl] 2-(trimethylazaniumyl)ethyl phosphate

C34H63N2O6P (626.4424)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C34H59O8P (626.3947)

(1-pentadecanoyloxy-3-phosphonooxypropan-2-yl) (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C34H59O8P (626.3947)

[(2R)-1-phosphonooxy-3-tridecanoyloxypropan-2-yl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C34H59O8P (626.3947)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C34H59O8P (626.3947)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (7E,10E,13E,16E)-icosa-7,10,13,16-tetraenoate

C34H59O8P (626.3947)

[(2R)-3-phosphonooxy-2-tridecanoyloxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C34H59O8P (626.3947)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (7E,10E,13E,16E)-icosa-7,10,13,16-tetraenoate

C34H59O8P (626.3947)

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate

C34H59O8P (626.3947)

[1-[(9E,12E)-pentadeca-9,12-dienoyl]oxy-3-phosphonooxypropan-2-yl] (4E,7E)-hexadeca-4,7-dienoate

C34H59O8P (626.3947)

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] (5E,8E,11E,14E)-icosa-5,8,11,14-tetraenoate

C34H59O8P (626.3947)

[1-[(E)-pentadec-9-enoyl]oxy-3-phosphonooxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C34H59O8P (626.3947)

2-[[2-hexanoyloxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO7P+ (626.4185)

2-[hydroxy-[3-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoxy]-2-octanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H61NO7P+ (626.4185)

2-[[2-butanoyloxy-3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO7P+ (626.4185)

2-[[3-[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO7P+ (626.4185)

2-[carboxy-[2-[(9Z,12Z)-hexadeca-9,12-dienoyl]oxy-3-nonanoyloxypropoxy]methoxy]ethyl-trimethylazanium

C35H64NO8+ (626.4632)

2-[carboxy-[2-[(9Z,12Z)-heptadeca-9,12-dienoyl]oxy-3-octanoyloxypropoxy]methoxy]ethyl-trimethylazanium

C35H64NO8+ (626.4632)

2-[hydroxy-[2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxy-3-octoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C34H61NO7P+ (626.4185)

2-[[2-acetyloxy-3-[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C34H61NO7P+ (626.4185)

castasterone 23-O-alpha-D-glucoside

C34H58O10 (626.403)

A brassinosteroid that is castasterone carrying an alpha-D-glucosyl residue at position O-23.

TG(36:6)

C39H62O6 (626.4546)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

NA-Orn 33:6

C38H62N2O5 (626.4658)

FAHFA 16:5/O-26:7

C42H58O4 (626.4335)

FAHFA 17:5/O-25:7

C42H58O4 (626.4335)

FAHFA 18:5/O-24:7

C42H58O4 (626.4335)

FAHFA 18:6/O-24:6

C42H58O4 (626.4335)

FAHFA 19:5/O-23:7

C42H58O4 (626.4335)

FAHFA 19:6/O-23:6

C42H58O4 (626.4335)

FAHFA 20:5/O-22:7

C42H58O4 (626.4335)

FAHFA 20:6/O-22:6

C42H58O4 (626.4335)

FAHFA 21:5/O-21:7

C42H58O4 (626.4335)

FAHFA 21:6/O-21:6

C42H58O4 (626.4335)

FAHFA 21:7/O-21:5

C42H58O4 (626.4335)

FAHFA 22:6/O-20:6

C42H58O4 (626.4335)

FAHFA 22:7/O-20:5

C42H58O4 (626.4335)

FAHFA 23:6/O-19:6

C42H58O4 (626.4335)

FAHFA 23:7/O-19:5

C42H58O4 (626.4335)

FAHFA 24:6/O-18:6

C42H58O4 (626.4335)

FAHFA 24:7/O-18:5

C42H58O4 (626.4335)

FAHFA 25:7/O-17:5

C42H58O4 (626.4335)

FAHFA 26:7/O-16:5

C42H58O4 (626.4335)

MGDG O-25:4;O

C34H58O10 (626.403)

MGDG O-26:3

C35H62O9 (626.4394)

MGMG 26:3

C35H62O9 (626.4394)

MGGA 25:3

C34H58O10 (626.403)

PA O-14:0/18:4

C35H63O7P (626.4311)

PA O-14:1/18:3

C35H63O7P (626.4311)

PA O-31:5;O

C34H59O8P (626.3947)

PA O-32:4

C35H63O7P (626.4311)

PA P-14:0/18:3

C35H63O7P (626.4311)

PA P-14:0/18:3 or PA O-14:1/18:3

C35H63O7P (626.4311)

PA P-18:1/13:3;O

C34H59O8P (626.3947)

PA P-32:3

C35H63O7P (626.4311)

PA P-32:3 or PA O-32:4

C35H63O7P (626.4311)

PA 11:0_20:4

C34H59O8P (626.3947)

PA 13:0_18:4

C34H59O8P (626.3947)

LPEth 30:4

C35H63O7P (626.4311)

LPM 31:4

C35H63O7P (626.4311)

PEth 29:4

C34H59O8P (626.3947)

PM 30:4

C34H59O8P (626.3947)

CerPE 14:0;O2/18:4

C34H63N2O6P (626.4424)

CerPE 14:1;O2/18:3

C34H63N2O6P (626.4424)

CerPE 14:2;O2/18:2

C34H63N2O6P (626.4424)

CerPE 15:2;O2/17:2

C34H63N2O6P (626.4424)

CerPE 32:4;O2

C34H63N2O6P (626.4424)

ST 28:0;O4;GlcA

C34H58O10 (626.403)

ST 28:1;O5;Hex

C34H58O10 (626.403)

ST 29:0;O4;Hex

C35H62O9 (626.4394)

CAE 15:3

C39H62O6 (626.4546)

5-hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0¹,⁵.0⁶,¹¹.0¹⁴,¹⁶]nonadeca-2,11-dien-4-yl hexadecanoate

C39H62O6 (626.4546)

5,6-dihydroxy-3-(3-hydroxy-5-oxo-4-tridecylfuran-2-ylidene)-7-tridecyl-1-benzofuran-2-one

C38H58O7 (626.4182)

5,5'-bis(3,7,11-trimethyldodeca-1,6,10-trien-3-yl)-[1,1'-biphenyl]-2,2',3,3'-tetrol

C42H58O4 (626.4335)

(1s,4s,5s,6r,13s,14r,16r,18r)-5-hydroxy-3,8,8,15,15,18-hexamethyl-19-oxo-7,9-dioxapentacyclo[11.5.1.0¹,⁵.0⁶,¹¹.0¹⁴,¹⁶]nonadeca-2,11-dien-4-yl hexadecanoate

C39H62O6 (626.4546)

blattellastanoside a

C35H59ClO7 (626.3949)

{"Ingredient_id": "HBIN018646","Ingredient_name": "blattellastanoside a","Alias": "NA","Ingredient_formula": "C35H59ClO7","Ingredient_Smile": "CCC(CCC(C)C1CCC2C1(CCC3C2CC(C45C3(CCC(C4O5)OC6C(C(C(C(O6)CO)O)O)O)C)Cl)C)C(C)C","Ingredient_weight": "627.29","OB_score": "NA","CAS_id": "149864-63-1","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6173","PubChem_id": "197598","DrugBank_id": "NA"}

(2r,3s,8s,13r,14s,19s)-8,19-dibutyl-10,13,21,24,26-pentahydroxy-3,14-dimethyltricyclo[18.2.2.2⁹,¹²]hexacosa-1(22),9,11,20,23,25-hexaen-2-yl acetate

C38H58O7 (626.4182)

3-{2-hydroxy-5-[(3r,6e)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]phenoxy}-5-[(3s,6e)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]benzene-1,2-diol

C42H58O4 (626.4335)

3-[2-hydroxy-4-(3,7,11-trimethyldodeca-1,6,10-trien-3-yl)phenoxy]-5-(3,7,11-trimethyldodeca-1,6,10-trien-3-yl)benzene-1,2-diol

C42H58O4 (626.4335)

5-[(3r,6e)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]-5'-[(3s,6e)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]-[1,1'-biphenyl]-2,2',3,3'-tetrol

C42H58O4 (626.4335)

(1r,2r,3s,3as,3br,5s,5as,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-(2-{[(2r,3r,4r,5r)-3,4-dihydroxy-5-methoxyoxan-2-yl]oxy}ethyl)-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-2,3,5,7-tetrol

C35H62O9 (626.4394)

3-[2-hydroxy-5-(3,7,11-trimethyldodeca-1,6,10-trien-3-yl)phenoxy]-5-(3,7,11-trimethyldodeca-1,6,10-trien-3-yl)benzene-1,2-diol

C42H58O4 (626.4335)

(2r,3r,4s,5s,6r)-2-[(2r)-4-[(1r,2s,4s,6s,7s,8r,9s,12s,13s,15r,16r,18s)-15,16-dihydroxy-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-yl]-2-methylbutoxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C34H58O10 (626.403)

n-[14-(benzoyloxy)-15-[1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]benzenecarboximidic acid

C40H54N2O4 (626.4083)

[(2s,3r,4r)-2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methyl octadecanoate

C38H58O7 (626.4182)

3-{1,10-dihydroxy-10-methyl-3-[2-methyl-4-(2,5,6,6-tetramethylcyclohex-1-en-1-yl)buta-1,3-dien-1-yl]-7-(1-oxopropan-2-ylidene)-2-oxaspiro[4.5]decan-6-yl}propyl octanoate

C39H62O6 (626.4546)

n-[(1s,3r,6s,7s,8r,11s,12s,14r,15s,16r)-14-(benzoyloxy)-15-[(1s)-1-(dimethylamino)ethyl]-7-(hydroxymethyl)-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]benzenecarboximidic acid

C40H54N2O4 (626.4083)

(2r,3r,4s,5r,6r)-2-{[(2r,9r,15r,16r)-9-chloro-15-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-2,16-dimethyl-7-oxapentacyclo[9.7.0.0²,⁸.0⁶,⁸.0¹²,¹⁶]octadecan-5-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C35H59ClO7 (626.3949)

3-{2-hydroxy-4-[(3r,6e)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]phenoxy}-5-[(3s,6e)-3,7,11-trimethyldodeca-1,6,10-trien-3-yl]benzene-1,2-diol

C42H58O4 (626.4335)

(1r,3r,3as,3br,5s,5as,6r,7s,9ar,9bs,11ar)-1-[(2r,5r)-5-(2-{[(2r,3r,4r,5r)-3,4-dihydroxy-5-methoxyoxan-2-yl]oxy}ethyl)-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,5,6,7-tetrol

C35H62O9 (626.4394)

1-(5-{2-[(3,4-dihydroxy-5-methoxyoxan-2-yl)oxy]ethyl}-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-2,3,5,7-tetrol

C35H62O9 (626.4394)

2-(4-{15,16-dihydroxy-6-methoxy-7,9,13-trimethyl-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosan-6-yl}-2-methylbutoxy)-6-(hydroxymethyl)oxane-3,4,5-triol

C34H58O10 (626.403)

[2-(4-hydroxy-3-methoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-3-yl]methyl octadecanoate

C38H58O7 (626.4182)

(2s,3r,4s,5r)-2-[2-(6-chlorododecyl)-3-hydroxy-5-tridecylphenoxy]oxane-3,4,5-triol

C36H63ClO6 (626.4313)

3-[(1r,3r,5r,6r,7z,10s)-1,10-dihydroxy-10-methyl-3-[(1e,3e)-2-methyl-4-[(5s)-2,5,6,6-tetramethylcyclohex-1-en-1-yl]buta-1,3-dien-1-yl]-7-(1-oxopropan-2-ylidene)-2-oxaspiro[4.5]decan-6-yl]propyl octanoate

C39H62O6 (626.4546)

5,6-dihydroxy-3-[(2e)-3-hydroxy-5-oxo-4-tridecylfuran-2-ylidene]-7-tridecyl-1-benzofuran-2-one

C38H58O7 (626.4182)